Source: International Congress 2017 – Pulmonary embolism
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
E. Klester (Barnaul, Altay Krai, Russian Federation). Septic pulmonary embolism in intravenous drug users.. 2353

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary complications of infective endocarditis in intravenous drug users Source: Eur Respir J 2001; 18: Suppl. 33, 521s Year: 2001 Comparison of local and systemic thrombolytic treatment for acute massive pulmonary embolism Source: Eur Respir J 2007; 30: Suppl. 51, 544s Year: 2007 Septic pulmonary embolism; report of three cases Source: Annual Congress 2007 - Venous thromboembolism Year: 2007 Pulmonary onset and complications of intravenous drug users infective endocarditis Source: International Congress 2018 – Diagnosis, prognostication and treatment of pulmonary embolism Year: 2018 Comparison of two regimens of oral anticoagulation in pulmonary embolism Source: Eur Respir J 2006; 28: Suppl. 50, 632s Year: 2006 Fibrinolysis with tenecteplase in the management of massive pulmonary embolism Source: Eur Respir J 2004; 24: Suppl. 48, 559s Year: 2004 The treatment of sub massive pulmonary embolism: Thrombolytic or heparin? Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism Year: 2012 Septic pulmonary embolism: clinical features and treatment outcome Source: Eur Respir J 2006; 28: Suppl. 50, 375s Year: 2006 Acute management of pulmonary embolism  Source: International Congress 2017 – Pulmonary emergencies year in review Year: 2017 Comparison of long –term outcomes of 50 mg rt-PA and 100 mg rt-PA in the management of acute pulmonary embolism Source: International Congress 2016 – Acute pulmonary embolism Year: 2016 Home treatment of pulmonary embolism Source: Virtual Congress 2021 – Pulmonary vascular diseases Year: 2021 Pulmonary embolism: who should receive thrombolysis? Source: International Congress 2014 – Current controversies in the management of acute pulmonary embolism Year: 2014 Treatment of acute pulmonary embolism Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2014 Treatment of acute pulmonary embolism Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2017 Treatment of acute pulmonary embolism Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease Year: 2018 Treatment of acute pulmonary embolism Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease Year: 2020 Hemorrhagic complications of treatment in patients with pulmonary embolism Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016 Anticoagulant treatment for acute pulmonary embolism: a pathophysiology-based clinical approach Source: Eur Respir J 2015; 45: 1142-1149 Year: 2015 Acute pulmonary embolism Source: International Congress 2018 – State of the art session: Pulmonary vascular diseases Year: 2018 Acute pulmonary embolism Source: Virtual Congress 2020 – Clinical grand round: revisiting current guidelines Year: 2020